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ABSTRACT
OBJECTIVE: To estimate rates of non-adherence to telemedicine strategies 
aimed at treating drug addiction.
METHODS: A systematic review was conducted of randomized controlled 
trials investigating different telemedicine treatment methods for drug 
addiction. The following databases were consulted between May 18, 2012 
and June 21, 2012: PubMed, PsycINFO, SciELO, Wiley (The Cochrane 
Library), Embase, Clinical trials and Google Scholar. The Grading of 
Recommendations Assessment, Development and Evaluation was used to 
evaluate the quality of the studies. The criteria evaluated were: appropriate 
sequence of data generation, allocation concealment, blinding, description 
of losses and exclusions and analysis by intention to treat. There were 274 
studies selected, of which 20 were analyzed.
RESULTS: Non-adherence rates varied between 15.0% and 70.0%. The 
interventions evaluated were of at least three months duration and, although 
they all used telemedicine as support, treatment methods differed. Regarding 
the quality of the studies, the values also varied from very poor to high quality. 
High quality studies showed better adherence rates, as did those using more 
than one technique of intervention and a limited treatment time. Mono-user 
studies showed better adherence rates than poly-user studies.
CONCLUSIONS: Rates of non-adherence to treatment involving 
telemedicine on the part of users of psycho-active substances differed 
considerably, depending on the country, the intervention method, follow-up 
time and substances used. Using more than one technique of intervention, 
short duration of treatment and the type of substance used by patients appear 
to facilitate adherence.
DESCRIPTORS: Drug Users. Patient Acceptance of Health Care. 
Patient Dropouts. Telemedicine. Review.
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Adherence to treatment for drug addiction is one of the 
biggest challenges in mental health clinical practice.42 It is 
measured by the dropout rate, expressed as a percentage, 
reflecting the losses in monitored individuals, for whatever 
reason, over a specific time. Poor adherence to treatment is 
responsible for many setbacks in treating drug addiction as 
it leads to reductions in the efficacy of treatment, to socio-
economic costs and to high mortality rates.2 Adherence is 
related to attitudes and beliefs regarding both the disease and 
the treatment, to level of knowledge concerning the disease, 
to personality and family structure characteristics and to 
the history and severity of the disease, as well as to factors 
linked to the type of intervention and to the health care 
professionals, which may or may not facilitate commitment 
to the therapy, thus increasing motivation to be treated.41
RESUMO
OBJETIVO: Estimar taxas de não adesão em intervenções com estratégias de 
telemedicina para tratamento de dependência química.
MÉTODOS: Foi realizada revisão sistemática de ensaios clínicos randomizados 
com diferentes métodos terapêuticos de dependência química que incluíam 
telemedicina. Foram consultadas as bases de dados PubMed, PsycINFO, 
SciELO, Wiley (The Cochrane Library), Embase e Clinical Trials e a plataforma 
Google Scholar no período de 18/4/2012 a 21/6/2012. Para avaliar a qualidade 
dos estudos, utilizou-se a escala Grading of Recommendations Assessment, 
Development and Evaluation. Os critérios avaliados foram: adequada sequência 
da geração de dados, ocultação da alocação, cegamento, descrição das perdas 
e exclusões e análises por intenção de tratar. Foram selecionados 274 estudos, 
dos quais 20 foram analisados.
RESULTADOS: As taxas de não adesão variaram entre 15,0% e 70,0%. As 
intervenções avaliadas possuíam no mínimo três meses de intervenção e, embora 
todos utilizassem a telemedicina como apoio, os métodos de tratamentos foram 
diferentes. Em relação à qualidade dos estudos, os valores também variaram 
entre muito baixa qualidade e alta qualidade. Os estudos com qualidade alta 
demonstraram maiores taxas de adesão, bem como aqueles que utilizaram mais 
de uma técnica de intervenção e tempo limitado de tratamento. Estudos com 
monousuários apontaram maiores taxas de adesão que estudos com poliusuários.
CONCLUSÕES:  As taxas de não adesão a tratamentos para usuários de substâncias 
psicoativas por meio de telemedicina apresentaram consideráveis diferenças, 
dependendo do país, método da intervenção, tempo de seguimento e substâncias 
utilizadas. O uso de mais de uma técnica de intervenção, tempo curto de tratamento 
e o tipo de substância utilizada pelos pacientes parecem facilitar a adesão.
DESCRITORES: Usuários de Drogas. Aceitação pelo Paciente de Cuidados 
de Saúde. Pacientes Desistentes do Tratamento. Telemedicina. Revisão.
INTRODUCTION
Health care professionals monitor these behaviors 
which include taking medication, attending appoint-
ments, accompaniment by the family and keeping in 
contact with support services, goals to be developed in 
order for the patient to improve their health. When the 
patient is more engaged, this is associated with better 
outcomes, whereas high levels of abandoning the moni-
toring and control make it difficult to evaluate the results 
of the interventions.3 In studies of efficacy, adherence is 
essential in order to examine issues such as internal and 
external validity, which are compromised when there are 
high losses of patients during treatment and monitoring.a
Drug addiction interventions using telemedicine, such 
as counselling via the telephone,23,26 internet38 and text 
messages14 aim to minimize the impact of abandoning 
treatment when offered together with fate-to-face 
a World Health Organization. Adherence to long-term therapies: evidence for action. Geneva; 2003 [cited 2010 Nov 23]. Available from: 
http://www.who.int/chp/knowledge/publications/adherence_report/en/
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interventions and often represent significant treatment 
alternatives when used in isolation.18,36
Even when it is easy to collect data, there are still few 
studies on dropout rates for isolated interventions or 
interventions in combination with face-to-face tele-
medicine based interventions.38 In addition, little is 
known about reasons for non-adherence and the specific 
components that can improve patient engagement 
in studies using telemedicine based interventions.17 
Randomized clinical trial with alcohol users showed 
that 80 of the 136 individuals who participated in an 
internet intervention completed the six-month moni-
toring period, representing a dropout rate of approxi-
mately 42.0%.5 In face-to-face interventions for drug 
addiction, generally, 50.0% of patients abandon treat-
ment before the end of the period.12 The rates have been 
studied from different perspectives. In Brazil, there are 
still few studies on telemedicine based interventions. 
The rate of adherence to treatment for drug addiction 
and the cultural, technological and disease-related 
factors that influence its effectiveness and the patients’ 
engagement with recommendations made through 
internet, telephone and text message are unknown.
The aim of this study was to estimate non-adherence 
rates in drug addiction treatment strategies using 
telemedicine.
METHODS
Randomized clinical trials meeting the following 
criteria were selected: a) testing different telemedi-
cine treatment methods in drug users and estimating 
factors associated with non-adherence rates; b) popu-
lation aged over 18; c) published in English between 
2000 and 2012. Telemedicine is a recent field of study 
and studies were found from 2000 onwards, hence the 
start date for the search. The authors searched for publi-
cations in English as the majority of publications were 
in this language.
The following search terms were used “randomized 
controlled trial”, “drug abuse”, “telemedicine” and its 
“mesh terms” in Google Scholar, and in the PubMed, 
PsycINFO, SciELO, Wiley (The Cochrane Library), 
Embase and Clinical trials databases. The search 
strategy included Boolean operators combining the 
limits and filters for each term. The studies found were 
then evaluated to verify the following characteristics: 
year of publication, demographic region in which the 
study was carried out, the psychoactive substance 
included in the studies, a description of the sample allo-
cation (randomization), blinding of outcomes, descrip-
tion of losses and exclusion, analysis by intention to 
treat, number of drug addicts (sample size), number of 
groups in the study, division of participants into control 
or intervention groups, type of intervention used with 
the groups, type of control used, stratification of groups 
by sex, age of the individuals being monitored and 
length of follow-up, the means used to apply the inter-
vention and the frequency with which it was applied, 
methods of measuring the results, control and interven-
tion group scores before and after the proposed inter-
vention, relationship of adherence for the control and 
intervention groups.
There were 274 records recovered. Of these, 253 were 
excluded after analysis of the title and the abstract 
(Figure). The remaining 20 articles were analyzed by 
2 investigators (LS and LRF) and compared in case of 
disagreement. Inclusion or exclusion was decided by 
a third assessor (TM).
In order to analyze the quality of the randomized clin-
ical trials, the GRADE scale was used.22 To ensure 
transparency and simplicity, the GRADE system clas-
sifies the quality of evidence into one of four levels, 
high, moderate, low and very low quality. Studies 
scoring 5/5 were considered high quality, score of 4/5 
and 3/5 were of moderate quality and 2/5 and 1/5 were 
low and very low quality, respectively. Evidence based 
on randomized clinical trials begins with high quality 
evidence, but confidence in the evidence can decrease 
for a variety of reasons including: limitations of the 
study, inconsistent results, indirect evaluations, inac-
curacy and indications of bias.22 Thus, the definitions 
of quality can be classified as:22
• High quality research: very unlikely that confidence 
in the estimate of effect changes;
• Moderate quality research: likely to have a signifi-
cant impact on confidence in the estimate of effect 
and may change the estimate;
• Low quality research: very likely to have a signifi-
cant impact on confidence in the estimate of effect 
and the estimate is likely to change;
• In very low quality research, the estimate of effect 
is very uncertain.
The clinical relevance of the studies included was eval-
uated using the United States Preventive Services Task 
Force (USPSTF) criteria24 in accordance with the five 
questions recommended by the Cochrane Back Review 
Group.43 Each question was classified as positive (+) if 
the relevant item was met; negative (-) if the item was 
not found and unclear (u) if the data were not available 
for analysis. Thus, the relevance of the interventions 
can be classified as:
• Good (5/5): consistent results, well designed, well 
conducted study of a representative population that 
directly evaluates effects on health results;
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• Reasonable (4/5 and 3/5): sufficient evidence to 
determine effects on health results, although the 
strength of relevancy is limited by the number, qua-
lity, size or consistency of the included study, or 
generalization for routine practice and the results;
• Limited or poor (2/5 and 1/5): there is insufficient 
evidence to evaluate the effects on health results 
due to the limited number of studies, inexplicable 
inconsistency, important faults in the design or con-
duct of the study, problems in the evaluation of lack 
of information on important results.
RESULTS
Of the 20 randomized clinical trials analyzed, the most 
commonly studied substance was alcohol (13 articles) 
and the majority of the research was on users of single 
psycho-active substances (13 articles). The number of 
patients involved in each study varied between 20 and 
230 in the studies with smaller samples and between 
358 and 873 in those with large samples. The partici-
pants’ ages varied between 24 and 58 years of age.
All of the studies used telemedicine combined with 
different interventions, such as brief motivational inter-
vention, individual therapy, group therapy, cognitive-
behavioral therapy – using strategies for coping, for 
identifying risky situations and identifying problems 
associated with use, among others – and preventing 
relapses. The non-adherence rate varied between 7.4% 
and 68.8%. The majority of studies followed patients 
for more than six months and described losses and 
exclusions; randomization and allocation concealment 
were adequate in half of the studies, 26.0% blinded the 
results and 63.0% analyzed according to intention to 
treat (Table 1).
Regarding the quality of the results analyzed, 50.0% 
were of moderate to high quality (Table 2). As for 
clinical relevance, 13 studies had a reasonable level of 
relevance (Table 3).
DISCUSSION
Lower rates of non-adherence are related to high 
quality studies evaluated using GRADE. Studies with 
single users, limited intervention time and which 
used different techniques to stop drug use appeared to 
increase rates of adherence. The interventions in the 
randomized clinical trials evaluated in this system-
atic review were of at least three months duration and, 
although all of them used telemedicine as primary or 
secondary support, the treatment methods differed, 
which may have affected adherence.
Treating drug addiction is a complex process. In 
addition to the factors related to treatment methods, 
coping abilities,9,33 motivation, self-efficacy,33 the 
users’ emotional state4 and social support13 influence 
the process of changing behavior, affecting adherence 
to treatment for substance abuse.8 For Brazilian alco-
holics, rates of non-adherence to drug addiction treat-
ment depend on the type of intervention, on the result 
related to abstinence, as they had to avoid consuming 
alcohol for six months after the intervention.45
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Total 274 records:
Pubmed: 48 records
EMBASE: 2 records
PsycINFO: 0 records
Google Scholar : 223 records
Cochrane: 1 record
Clinical trial: 0 records 
271 records were included
after removing duplicates
3 duplicates removed
1 record excluded after full reading
because it did not meet
eligibility criteria
251 records were excluded based on
review of the title and/or abstract
20 records eligible for full reading
+ 1 record found after
reviewing references
20 randomly selected
clinical trials
Figure. Flowchart of the stages of the systematic review.
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Table 1. Characteristics and main results of the selected randomized clinical trials, GRADEa score and clinical relevance score. 
(N = 20)
Source/Country in which 
the study was conduc-
ted /Substance stu-
died/Sample size
Type of intervention/Method to mini-
mize abandonment/Non-adherence rate
Outcome measured
GRADE totalb 
– Clinical 
relevancec
Agyapong et al (2012)1
Ireland
Alcohol
N = 54
SMS/control
Not used
7.4% in 3 months
Text messaging support 
showed improvement in 
outcomes for patients with 
depression and comorbidity 
(alcohol dependence).
5/5-5/5
Blankers M et al (2011)5
Holland
Alcohol
N = 205
Cognitive behavioral therapy and 
motivational interviewing
online/internet
Motivational e-mails, telephone calls 
to collect data, 15 Euro voucher for 
every questionnaire completed
41.0% in 6 months
Reducing the number 
of units of alcohol per 
week in 6 months.
4/5-5/5
Joseph A et al (2011)28
United States
Tobacco
N = 443
Prevalence of relapse and 
telephone /usual care
Not used
8.4% in 18 months
The approach increased 
tobacco abstinence in the 
short and long term.
5/5-5/5
McKay J et al (2011)34
United States
Alcohol
N = 252
Counselling and telephone monitoring/
telephone monitoring/usual treatment
Not used
26.2% in 24 months
Telephone monitoring 
and counseling decreased 
% of days of alcohol 
consumption up to 18 
months of intervention.
5/5-5/5
Postel M et al (2011)38
Holland
Alcohol
N = 924
Internet/waiting list
Not used
Non-adherence rate not estimated
Gender, educational level, age, 
initial intake and motivational 
level were predictors of 
completing treatment.
1/5-2/5
Whittaker R et 
al (2011)48
New Zealand
Tobacco
N = 226
Video message/control
Not used
27.0% in 6 months
Efficacy not shown in 
the tested intervention. 
Dropout rates were 
high in both groups.
5/5-3/5
Fernandes S et 
al (2010)18
Brazil
Marijuana
N = 1.744
Brief, motivational telephone 
interview/telephone control
Not used
68.8% in 6 months
Positive efficacy for 
stopping marijuana use.
2/5-3/5
Girard B et al (2010)20
Canada
Tobacco
N = 91
Virtual game
Not used
60.4% in 6 months
E-cigarettes led to a 
significant reduction in 
nicotine dependence, 
abstinence and dropout rates.
5/5-4/5
Zanjani F et al (2010)49
United States
Tobacco
N = 113
Brief motivational telephone 
interview/usual care
Participants in the intervention group received 
a letter to reinforce presence in the continued 
treatment using motivational components.
22.1% in 6 months
The proposed intervention 
did not lead to a significant 
improvement in the results 
of psychiatric health.
3/5-5/5
Eberhard S et al (2009)15
Sweden
Alcohol
N = 344
Motivational telephone interview 
(1 session-15 min.)
Intervention group received 
feedback at the beginning
12.5% in 6 months
Alcohol consumption 
reduced to safe levels.
1/5-2/5
Kavanagh D & 
Connolly J (2009)30
Australia
Alcohol
N = 204
Letter and telephone: immediate 
treatment/delayed treatment
Not used
52.9% in 12 months
High levels of adherence to 
treatment and substantial 
reduction of alcohol use.
5/5-4/5
Continue
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Of the studies evaluated, six1,6,28,30,34,48 were of high 
quality and the clinical relevance of four of these was 
good.1,6,28,34 Considering the impact of non-adherence 
rates in each of the six best studies, a difference in non-
adherence rates can be identified, even in well-designed 
studies. Agyapong et al1 used SMS (an effective 
technique often used on studies of adherence,a as, with 
the development of new technology, individuals are 
increasingly more interconnected, due to growing use 
of this technology), and had the lowest non-adherence 
rate of the randomized clinical trials. Thus, reminders 
or messages received during the treatment period 
Continuation
Kay-Lambkin F 
et al (2009)31
Australia
Alcohol and marijuana
N = 97
Computerized cognitive behavioral 
therapy/brief intervention
Not used
28.9% in 12 months
Marijuana use and hazardous 
use of substances reduced 
with computerized therapy.
4/5-5/5
Litt M et al (2009)33
United States
Alcohol and marijuana
N = 110
Individual treatment program (cell phone)/
package of cognitive-behavioral therapy
Not used
15.5% in 16 weeks
Intervention decreased 
the days of alcohol 
intake and increased use 
of coping strategies.
1/5-2/5
Brendryen H et al (2008)6
Norway
Tobacco
N = 290
Messages via Internet, e-mail and cellular 
(SMS) (I) X Self-help booklet (C)
The proposed intervention already included 
the method of minimization of abandonment
32.6% in 12 months
Better rates of abstinence 
from tobacco.
5/5-5/5
El-Khorazaty M 
et al (2007)16
United States
Polydrug
N = 1.070
Educational intervention and multimodal 
integrative counseling /usual care
Telephone contacts, current contact 
information, financial incentives, training of 
staff in the recruitment and implementation 
of the study, salary support for staff, quick 
resolution to the problems that the team could 
have, continuous monitoring of the study
20.0% in 9 months
Specific recruitment 
and retention strategies 
increased the rate of minority 
participation in trials.
2/5-2/5
Hubbard R et al (2007)26
United States
Polydrug
N = 339
Telephone group/standard care group
Both groups were reminded to enroll in 
outpatient and continuing care following; 
reminded of the dates of the calls (I)
Not used
29.2% in 13 weeks
Well-developed telephone 
approaches facilitate 
the approaches between 
professional and patient.
4/5-5/5
Parker D et al (2007)37
United States
Tobacco
N = 1.065
Motivational interview (telephone), 
incentives, self-help material/incentives 
and self-help material/self-help material
Joining a monetary incentive program (30 
days of abstinence confirmed by screening)
30.7% in 6 months (postpartum)
Telephone counseling was 
well received by pregnant 
low-income women. 
The cessation rate was 
higher among those who 
received the intervention.
2/5-4/5
Vidrine D et al (2006)47
United States
Tobacco
N = 95
Telephone/standard care
Not used
18.9% in 3 months
Intervention by phone 
showed greater reduction 
in anxiety and depression, 
and increased self-efficacy.
1/5-2/5
Currie S et al (2004)11
Canada
Alcohol
N = 57 
Individual face-to-face treatment (I) 
X self-help/telephone support (C)
Not used
36.0% X 50.0% in 6 months
Better sleep parameters 
for both groups and 
equal levels of lapse and 
relapse to alcohol.
1/5-2/5
Hall J & Hubert 
D (2000)23
United States
Polydrug
N = 230
Case management/interactive 
voice response system/control
Not used
Non-adherence rate not estimated
The use of telemedicine 
facilitated interaction 
with customers and 
decreased costs.
0/5-1/5
I: Intervention Group; C: Control Group
a GRADE study quality scale, Guyatt GH et al (2008).
b The complete data for the scale are described in Table 3.
c The complete data for the scale are described in Table 4.
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contributed to better adherence.25 On the other hand, the 
study by Agyapong et al,1 when compared to the other 
good quality ones, had the shortest follow-up time.
Lower rates of non-adherence are also found in shorter 
treatments, or those with a limited time, irrespective 
of the use of telemedicine. According to a meta-anal-
ysis of data on face-to-face therapy,44 a short follow-
up time is more effective than treatments that have no 
time limit or even those in which there is a limited, 
albeit extensive, period. Another important factor in the 
study by Agyapong et al1 is that the treatment was only 
for alcohol users, and the literature describes how it is 
easier for users of a single substance to follow treat-
ment and stop taking it than for users of more than one 
drug.39 The study using pharmacological treatment28 for 
tobacco had a low non-adherence rate, which may be 
explained by the use of medication that, by increasing 
rates of quitting,21,27 may motivate the patient to adhere 
more to treatment.46 Moreover, research conducted 
with smokers shows that pharmacological treatment is 
widely studied,35 with positive results for treating nico-
tine dependence.21,27 It is probable that the use of strat-
egies to prevent relapse with longer follow-up than in 
the other studies (one year) and the patients’ financial 
incentive ($25 per follow up conducted) may also have 
positively influenced adherence results.
The study of users of alcohol alone34 had a higher 
non-adherence rate compared with other good quality 
studies. Alcohol dependence is also associated with 
high rates of non-adherence in face-to-face treatment.45 
Even with more follow-up, the patients in this study34 
were monitored for longer than in other studies, prob-
ably due to the use of a combination of different tech-
niques.34 Making use of more than one technique, 
including using telemedicine, is a good alternative for 
treating drug users,36 as, when the intervention contains 
different tools and approaches,7 there is a greater 
possibility of the individual being engaged,2 and the 
results of the treatment may also be better.29 The study 
by Brendryen et al6 highlights using the telemedicine 
Table 2. Quality of the studies according to GRADE criteriaa: randomized clinical trials.
First author/Year of publication Proper 
sequence of 
data generation
Allocation 
concealment
Blinding Description 
of losses and 
exclusions
Analysis by 
intention to treat
Score
Agyapong et al (2012)1 Yes Yes Yes Yes Yes 5/5
Blankers et al (2011)5 Yes Yes No Yes Yes 4/5
Joseph et al (2011)28 Yes Yes Yes Yes Yes 5/5
McKay et al (2011)34 Yes Yes Yes Yes Yes 5/5
Postel et al (2011)38 No No No Yes No 1/5
Whittaker et al (2011)48 Yes Yes Yes Yes Yes 5/5
Fernandes et al (2010)18 Yes No No Yes No 2/5
Girard et al (2010)20 No No No Yes Yes 2/5
Zanjani et al (2010)49 Yes Yes No Yes Unclear 3/5
Eberhard et al (2009)15 No No No No Yes 1/5
Kavanagh & Connolly (2009)30 Yes Yes Yes Yes Yes 5/5
Kay-Lambkin et al (2009)31 Yes Yes No Yes Yes 4/5
Litt et al (2009)33 No No No Yes Unclear 1/5
Brendryen et al (2008)6 Yes Yes Yes Yes Yes 5/5
El-Khorazaty et al (2007)16 No No No Yes Yes 2/5
Hubbardi et al (2007)26 Yes Yes No Yes Yes 4/5
Parker et al (2007)37 No No No Yes Yes 2/5
Vidrine et al (2006)47 No No No Yes No 1/5
Currie et al (2004)11 No No No Yes No 1/5
Hall & Hubert (2000)23 No No No No No 0/5
a GRADE study quality questionnaire, Guyatt GH et al (2008).
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Happy Ending technique, consisting of an intense stop 
smoking program with the help of contact via e-mail, 
text messages, a helpline for dealing with cravings 
and a system to prevent relapse. Moreover, it empha-
sizes how psychological support can be efficaciously 
provided through modern communication technology 
with excellent results.6 The study by Brendryen et al6 
was of high quality and had better results for stopping 
smoking when technological interventions were used, 
confirming that well-designed studies have more reli-
able results.
As the quality of the studies included in this systematic 
review decreased, there was an increase in non-adher-
ence rates. This shows that in research that is more reli-
able in estimating effect – represents the effect present 
in the population and not only in the sample studied – 
there are better adherence rates.10 In moderate quality 
studies,5,26,31,49 only that of Blankers et al5 had high rates 
of non-adherence (41.0% in six months) and the others 
showed little variation (between 22.0% and 29.0%). 
Regarding clinical relevance of the moderate quality 
studies, only that of Blankers et al5 had reasonable rele-
vance, whereas the others met the criteria evaluated 
with good clinical relevance. Although the study by 
Blankers et al5 was conducted solely with alcohol users, 
the only intervention technique used was that of online 
therapy, in which there was no contact with a therapist 
and the individuals was self-guided by the programs 
used. The authors themselves highlight the technique as 
being effective but limited to reduced alcohol consump-
tion. Kay-Lambkin et al31 and Zanjani et al49 used brief 
intervention techniques associated with other interven-
tions. The former presented an intervention for alcohol 
and marijuana and had a higher non-adherence rate.31 
This may be related to use of two substances and to the 
follow-up time, as well as to the characteristics of the 
profile of those who use marijuana19 who often have 
difficulty viewing their marijuana consumption as prob-
lematic.40 The treatment in the study by Zanjani et al49 
Tabela 3. Relevância clínica dos estudos selecionados.
Source
Description 
of patients
Description of 
interventions and 
definition of treatment
Results with 
clinical 
relevance
Clinical 
importance
Benefits x Potential 
harm
Total
Agyapong et al (2012)1 + + + + + 5/5
Blankers et al (2011)5 + + + + + 5/5
Joseph et al (2011)28 + + + + + 5/5
McKay et al (2011)34 + + + + + 5/5
Postel et al (2011)38 + + - - - 2/5
Whittaker et al (2011)48 + + + - - 3/5
Fernandes et al (2010)18 + + - + - 3/5
Girard et al (2010)20 + + - + + 4/5
Zanjani et al (2010)49 + + + + + 5/5
Eberhard et al (2009)15 + + - - - 2/5
Kavanagh & Connolly 
(2009)30
+ + + + - 4/5
Kay-Lambkin et al 
(2009)31
+ + + + + 5/5
Litt et al (2009)33 + + - - - 2/5
Brendryen et al (2008)6 + + + + + 5/5
El-Khorazaty et al 
(2007)16
+ + - - - 2/5
Hubbardi et al (2007)26 + + + + + 5/5
Parker et al (2007)37 + + - + + 4/5
Vidrine et al (2006)47 + + - - - 2/5
Currie et al (2004)11 + + - - - 2/5
Hall & Hubert (2000)23 - + - - - 1/5
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was conducted solely with smokers, with a six-month 
follow-up to facilitate adherence.44 Hubbard et al26 only 
used groups via telephone with tele-counselors and indi-
cated that in-person clinical monitoring is necessary to 
keep abstinence.
Studies considered to be of16,18,20,37 have high non-
adherence rates, which may be explained by difficulty 
maintaining the effect estimate.10 The evaluation of the 
results for the discussion of adherence to telemedicine 
were based on the relevance of the studies that, in this 
case, may be considered of poor reliability. Using a 
greater number of techniques contributed to higher 
adherence rates16,37 and adherence to interventions may 
increase in drug users who have made various attempts 
to stay clean,32 irrespective of whether a face-to-face or 
telemedicine intervention was used.
Among the limitations of this study is the fact that the 
therapies used in the studies used different telemedicine 
strategies and had different periods of follow-up, which 
makes it difficult to compare them. Another limitation 
is that the studies were on treatments for different types 
of substances and included users of single substances 
or poly drug users.
Despite the limitations found, it was possible to observe 
that certain factors favor non-adherence to treatment for 
drug addiction using telemedicine. Adherence is better 
when more than one intervention technique is used and 
when the treatment time is shorter.
In some countries, the use of telemedicine is of recent 
date. Treatments that use this tool are still unknown 
to many patients and professionals, which leads us to 
believe that this decreases confidence in the possibility 
of a positive result and leads to non-adherence.
As rates of non-adherence are high, more research is 
necessary on personal and socioeducational character-
istics of patients which affect non-adherence to inter-
ventions using telemedicine technology.
1. Agyapong VIO, Ahern S, McLoughlin DM, Farren CK. 
Supportive text messaging for depression and comorbid 
alcohol use disorder: single-blind randomised 
trial. J Affect Disord. 2012;141(2-3):168-76. 
DOI:10.1016/j.jad.2012.02.040
2. Amato L, Minozzi S, Davoli M, Vecchi S, Ferri 
MM, Mayet S. Psychosocial and pharmacological 
treatments versus pharmacological treatment for 
opioid detoxification. Cochrane Database Syst Rev. 
2008;(3):CD005031. DOI:10.1002/14651858
3. Ball SA, Carroll KM, Canning-Ball M, 
Rounsaville BJ. Reasons for dropout from drug 
abuse treatment: Symptoms, personality, and 
motivation. Addict Behav. 2006;31(2):320-30. 
DOI:10.1016/j.addbeh.2005.05.013
4. Baker TB, Piper ME, McCarthy DE, Majeskie MR, 
Fiore MC. Addiction motivation reformulated: 
an affective processing model of negative 
reinforcement. Psychol Rev. 2004;111(1):33-51. 
DOI:10.1037/0033-295X.111.1.33
5. Blankers M, Koeter MW, Schippers GM. Internet 
therapy versus internet self-help versus no treatment 
for problematic alcohol use: A randomized controlled 
trial. J Consult Clin Psychol. 2011;79(3):330-41. 
DOI:10.1037/a0023498
6. Brendryen H, Drozd F, Kraft P. A digital smoking 
cessation program delivered through internet and cell 
phone without nicotine replacement (happy ending): 
randomized controlled trial. J Med Internet Res. 
2008;10(5):e51. DOI:10.2196/jmir.1005
7. Bock BC, Graham AL, Whiteley JA, Stoddard JL. 
A review of web-assisted tobacco interventions 
(WATIs). J Med Internet Res. 2008;10(5):e39. 
DOI:10.2196/jmir.989
8. Carroll KM, Ball SA, Nich C, Martino S, 
Frankforter TL, Farentinos C, et al. Motivational 
interviewing to improve treatment engagement 
and outcome in individuals seeking treatment 
for substance abuse: A multisite effectiveness 
study. Drug Alcohol Depend. 2006;81(3):301-12. 
DOI:10.1016/j.drugalcdep.2005.08.002
9. Chung T, Langenbucher J, Labouvie E, Pandina RJ, 
Moos RH. Changes in alcoholic patients’ coping 
responses predict 12-month treatment outcomes. 
J Consult Clin Psychol. 2001;69(1):92-100. 
DOI:10.1037//0022-006X.69.1.92
10. Coutinho ESF, Cunha GM. Conceitos 
básicos de epidemiologia e estatística para 
a leitura de ensaios clínicos controlados. 
Rev Bras Psiquiatr. 2005;27(2):146-51. 
DOI:10.1590/S1516-44462005000200015
11. Currie SR, Clark S, Hodgins DC, El-Guebaly N. 
Randomized controlled trial of brief cognitive-
behavioural interventions for insomnia in recovering 
alcoholics. Addiction. 2004;99(9):1121-32. 
DOI:10.1111/j.1360-0443.2004.00835.x
12. de Weert-van Oene GH, Burger H, Grobbee DE, 
Schrijvers AJ. Identification of patients at high 
risk of noncompliance in substance dependence 
treatment. Eur Addict Res. 2007;13(2)74-80. 
DOI:10.1159/000097936
13. Dobkin PL, Civita M, Paraherakis A, Gill K. The 
role of functional social support in treatment 
retention and outcomes among outpatient adult 
substance abusers. Addiction. 2002;97(3):347-56. 
DOI:10.1046/j.1360-0443.2002.00083.x
14. Downer SR, Meara JG, Da Costa AC. Use of SMS text 
messaging to improve outpatient attendance. Med J 
Aust. 2005;183(7):366-8.
REFERENCES
530 Telemedicine and drug addiction Moreira TC et al
15. Eberhard S, Nordström G, Höglund P, Öjehagen 
A. Secondary prevention of hazardous alcohol 
consumption in psychiatric out-patients: a 
randomised controlled study. Soc Psychiatry 
Psychiatr Epidemiol. 2009;44(12):1013-21. 
DOI:10.1007/s00127-009-0023-7
16. El-Khorazaty MN, Johnson AA, Kiely M, El-Mohandes 
AAE, Subramanian S, Laryea HA, et al. Recruitment and 
retention of low-income minority women in a behavioral 
intervention to reduce smoking, depression, and intimate 
partner violence during pregnancy. BMC Public Health. 
2007;7:233. DOI:10.1186/1471-2458-7-233
17. Eysenbach G. The law of attrition. J Med Internet Res. 
2005;7(1):e11. DOI:10.2196/jmir.7.1.e11
18. Fernandes S, Ferigolo M, Benchaya MC, Moreira TC, 
Pierozan PS, Mazoni CG, et al. Brief Motivational 
Intervention and telemedicine: A new perspective 
of treatment to marijuana users. Addict Behav. 
2010;35(8):750-5. DOI:10.1016/j.addbeh.2010.03.001
19. Fernandes S, Ferigolo M, Benchaya MC, 
Pierozan PS, Moreira TC, Santos V, et al. Abuso e 
dependência de maconha: comparação entre sexos 
e preparação para mudanças comportamentais 
entre usuários que iniciam a busca por tratamento. 
Rev Psiquiatr Rio Gd Sul. 2010;32(3):80-5. 
DOI:10.1590/S0101-81082010005000004
20. Girard B, Turcotte V, Bouchard S, Girard B. Crushing 
virtual cigarettes reduces tobacco addiction and 
treatment discontinuation. Cyberpsychol Behav. 
2009;12(5):477-83. DOI:10.1089/cpb.2009.0118
21. Gourlay SG, Stead LF, Benowitz NL. Clonidine for 
smoking cessation. Cochrane Database Syst Rev. 
2004;(3):CD000058. DOI:10.1002/14651858
22. Guyatt GH, Oxman AD, Vist G, Kunz R, Falck-Ytter 
Y, Alonso-Coello P, et al. GRADE: an emerging 
consensus on rating quality of evidence and strength 
of recommendations. BMJ. 2008;336(7650):924-6. 
DOI:10.1136/bmj.39489.470347.AD
23. Hall JA, Huber DL. Telephone management in 
substance abuse treatment. Telemed J E Health. 
2000;6(4):401-7. DOI:10.1089/15305620050503870
24. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow 
CD, Teutsch SM, et al. Methods Work Group, 
Third US Preventive Services Task Force. Current 
methods of the US Preventive Services Task Force. 
Am J Prevent Med. 2001;20(3Suppl):21-35. 
DOI:10.1016/S0749-3797(01)00261-6
25. Hasvold PE, Wootton R. Use of telephone and 
SMS reminders to improve attendance at hospital 
appointments: a systematic review. J Telemed Telecare. 
2011;17(7):358-64. DOI:10.1258/jtt.2011.110707
26. Hubbard RL, Leimberger JD, Haynes L, Patkar 
AA, Holter J, Liepman MR, et al. Telephone 
enhancement of long-term engagement 
(TELE) in continuing care for substance abuse 
treatment: a NIDA clinical trials network 
(CTN) study. Am J Addict. 2007;16(6):495-502. 
DOI:10.1080/10550490701641678
27. Hughes JR. Motivating and helping smokers to stop 
smoking. J Gen Intern Med. 2003;18(12):1053-7. 
DOI: 10.1111/j.1525-1497.2003.20640.x
28. Joseph AM, Fu SS, Lindgren B, Rothman AJ, Kodl M, 
Lando H, et al. Chronic Disease Management for 
Tobacco Dependence: a randomized, controlled 
trial. Arch Intern Med. 2011;171(21):1894-900. 
DOI:10.1001/archinternmed.2011.500
29. Jungerman FS. Boas Práticas nas abordagens 
psicossociais da dependência de substâncias. In: 
Cordeiro DC, Figlie NB, Laranjeira R. Boas práticas no 
tratamento do uso e dependência de substâncias. São 
Paulo: Roca; 2007. p. 174-5.
30. Kavanagh D, Connolly JM. Mailed treatment 
to augment primary care for alcohol 
disorders: a randomised controlled trial. 
Drug Alcohol Rev. 2009;28(1):73-80. 
DOI:10.1111/j.1465-3362.2008.00011.x
31. Kay-Lambkin FJ, Baker AL, Lewin TJ, Carr VJ. 
Computer-based psychological treatment for 
comorbid depression and problematic alcohol and/
or cannabis use: a randomized controlled trial of 
clinical efficacy. Addiction. 2009;104(3):378-88. 
DOI:10.1111/j.1360-0443.2008.02444.x
32. Koob GF, Le Moal M. Neurobiological mechanisms for 
opponent motivational processes in addiction. Philos 
Trans R Soc Lond B Biol Sci. 2008;363(1507):3113-23. 
DOI:10.1098/rstb.2008.0094
33. Litt MD, Kadden RM, Cooney NL, Kabela E. 
Coping skills and treatment outcomes in cognitive-
behavioral and interactional group therapy for 
alcoholism. J Consult Clin Psychol. 2003;71(1):118-28. 
DOI:10.1037/0022-006X.71.1.118
34. McKay JR, Van Horn D, Oslin DW, Ivey M, 
Drapkin ML, Coviello DM, et al. Extended 
telephone-based continuing care for alcohol 
dependence: 24-month outcomes and subgroup 
analyses. Addiction. 2011;106(10):1760-9. 
DOI:10.1111/j.1360-0443.2011.03483.x
35. Mitrouska I, Bouloukaki I, Siafakas NM. 
Pharmacological approaches to smoking cessation. 
Pulm Pharmacol Ther. 2007;20(3):220-32. 
DOI:10.1016/j.pupt.2005.10.012
36. Obermayer JL, Riley WT, Asif O, Jean-Mary J. 
College smoking-cessation using cell phone text 
messaging. J Am Coll Health. 2004;53(2):71-8. 
DOI:10.3200/JACH.53.2.71-78
37. Parker DR, Windsor RA, Roberts MB, Hecht J, 
Hardy NV, Strolla LO, et al. Feasibility, cost, 
and cost-effectiveness of a telephone-based 
motivational intervention for underserved pregnant 
smokers. Nicotine Tob Res. 2007;9(10):1043-51. 
DOI:10.1080/14622200701591617
38. Postel MG, de Haan HA, ter Huurne ED, van der 
Palen J, Becker ES, de Jong CAJ. Attrition in web-based 
treatment for problem drinkers. J Med Internet Res. 
2011;13(4):e117. DOI:10.2196/jmir.1811
39. Ray AL, Hutchison R, Bryan A. Psychosocial 
predictors of treatment outcome, dropout and 
change processes in a pharmacological clinical 
trial for alcohol dependence. Addict Disord 
Their Treat. 2006;5(4):179-90. DOI:10.1097/01.
adt.0000210701.63165.5a
531Rev Saúde Pública 2014;48(3):521-531
40. Reniscow K, Smith M, Harrison L, Drucker 
E. Correlates of occasional cigarette and 
marijuana use: are teens harm reducing? 
Addict Behav. 1999;24(2):251-66. 
DOI:10.1016/S0306-4603(98)00059-8
41. Rosa AR, Kapczinski F, Oliva R, Stein A, Barros 
HMT. Monitoramento da adesão ao tratamento 
com lítio. Rev Psiquiatr Clin. 2006;33(5):249-61. 
DOI:10.1590/S0101-60832006000500005
42. Rutkowski BA, Gallon S, Rawson RA, Freese TE, 
Bruehl A, Crèvecoeur-Macphail D, et al. Improving 
client engagement and retention in treatment: The 
Los Angeles County experience. J Subst Abuse Treat. 
2010;39(1):78-86. DOI:10.1016/j.jsat.2010.03.015
43. Staal JB, de Bie R, de Vet HC, Hildebrandt J, 
Nelemans P. Injection therapy for subacute and 
chronic low-back pain. Cochrane Database Syst Rev. 
2008;16(3):CD001824.
44. Swift JK, Greenberg RP. Premature discontinuation in 
adult psychotherapy: a meta-analysis. J Consult Clin 
Psychol. 2012;80(4):547-59. DOI:10.1037/a0028226
45. Terra MB, Barros HMT, Stein AT, Figueira I, Palermo 
LH, Athayde LD, et al. Do Alcoholics Anonymous 
Groups Really Work? Factors of Adherence in 
a Brazilian Sample of Hospitalized Alcohol 
Dependents. Am J Addict. 2008;17(1):48-53. 
DOI:10.1080/10550490701756393
46. Velicer WF, Prochaska JO, Fava JL, Norman 
GJ, Redding CA. Smoking cessation and stress 
management: Applications of the Transtheoretical 
Model of behavior change. Homeostasis Hlth Dis. 
1998;38(5-6):216-33.
47. Vidrine DJ, Arduino RC, Gritz ER. Impact of a cell 
phone intervention on mediating mechanisms of 
smoking cessation in individuals living with HIV/
AIDS. Nicotine Tob Res. 2006;8(Suppl 1):S103-8. 
DOI:10.1080/14622200601039451
48. Whittaker R, Dorey E, Bramley D, Bullen C, Denny S, 
Elley CR, et al. A theory-based video messaging mobile 
phone intervention for smoking cessation: randomized 
controlled trial. J Med Internet Res. 2011;13(1):e10. 
DOI:10.2196/jmir.1553
49. Zanjani F, Bush H, Oslin D. Telephone-
based psychiatric referral-care management 
intervention health outcomes. Telemed J E Health. 
2010;16(5):543-50. DOI:10.1089/tmj.2009.0139
Article based on the Doctoral thesis of Moreira TC, entitled: “Qualidade de Vida e Voz em usuários de substâncias 
psicoativas”, presented to the Programa de Pós-Graduação em Ciências da Saúde of the Universidade Federal de Ciências 
da Saúde de Porto Alegre, in 2013.
This study was supported by the Secretaria Nacional de Políticas sobre Drogas, Associação Mário Tannhauser de 
Ensino, Pesquisa e Assistência (SENAD/AMTEPA – 00187.000520/2010-61 Term 04/2010), by the Conselho Nacional 
de Desenvolvimento Científico e Tecnológico (CNPq) through a research productivity grant 1C (HMTB – Process 
303742/2010-0, in 2011-2014) and by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) through 
doctoral grants (TCM: 95414720010, in 2010 and LRF: 00331585090, in 2012).
The authors declare that there is no conflict of interest.
